BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 17576235)

  • 1. The association between endothelin-1 gene polymorphisms and susceptibility to vitiligo in a Korean population.
    Kim HJ; Choi CP; Uhm YK; Kim YI; Lee JW; Yoon SH; Chung JH; Lee MH
    Exp Dermatol; 2007 Jul; 16(7):561-6. PubMed ID: 17576235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients.
    Jin SY; Park HH; Li GZ; Lee HJ; Hong MS; Park HJ; Park HK; Seo JC; Yim SV; Chung JH; Lee MH
    J Dermatol Sci; 2004 Sep; 35(3):181-6. PubMed ID: 15381239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations.
    Li M; Gao Y; Li C; Liu L; Li K; Gao L; Wang G; Zhang Z; Gao T
    J Dermatol Sci; 2009 Mar; 53(3):176-81. PubMed ID: 19004621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-4 genetic variants correlate with its transcript and protein levels in patients with vitiligo.
    Imran M; Laddha NC; Dwivedi M; Mansuri MS; Singh J; Rani R; Gokhale RS; Sharma VK; Marfatia YS; Begum R
    Br J Dermatol; 2012 Aug; 167(2):314-23. PubMed ID: 22512783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population.
    Park HH; Ha E; Uhm YK; Jin SY; Kim YJ; Chung JH; Lee MH
    Exp Dermatol; 2006 May; 15(5):377-80. PubMed ID: 16630078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo.
    Yazici AC; Erdal ME; Kaya TI; Ikizoglu G; Savasoglu K; Camdeviren H; Tursen U
    Arch Dermatol Res; 2006 Jun; 298(1):46-9. PubMed ID: 16691430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of genetic association of promoter and structural variants of mannan-binding lectin (MBL2) gene with susceptibility to generalized vitiligo.
    Dwivedi M; Gupta K; Gulla KC; Laddha NC; Hajela K; Begum R
    Br J Dermatol; 2009 Jul; 161(1):63-9. PubMed ID: 19416237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo.
    Gavalas NG; Akhtar S; Gawkrodger DJ; Watson PF; Weetman AP; Kemp EH
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1586-91. PubMed ID: 16729966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes.
    Li H; Louey JW; Choy KW; Liu DT; Chan WM; Chan YM; Fung NS; Fan BJ; Baum L; Chan JC; Lam DS; Pang CP
    Mol Vis; 2008 Sep; 14():1698-704. PubMed ID: 18806884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of single nucleotide polymorphisms of Nrf2 promoter region with susceptibility to vitiligo].
    Zhou MN; Xu AE; Lu LJ; Li YW; Zhao DK; Guan CP
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):969-72. PubMed ID: 18756969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients.
    Ulker M; Yazisiz V; Sallakci N; Avci AB; Sanlioglu S; Yegin O; Terzioglu E
    Int J Immunogenet; 2009 Aug; 36(4):245-50. PubMed ID: 19602000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients.
    Namian AM; Shahbaz S; Salmanpoor R; Namazi MR; Dehghani F; Kamali-Sarvestani E
    Arch Dermatol Res; 2009 Jan; 301(1):21-5. PubMed ID: 18820938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of glutathione S-transferase gene polymorphisms (GSTM1 and GSTT1) of vitiligo in Korean population.
    Uhm YK; Yoon SH; Kang IJ; Chung JH; Yim SV; Lee MH
    Life Sci; 2007 Jun; 81(3):223-7. PubMed ID: 17568619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
    Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
    J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of myeloperoxidase promotor polymorphism and enzyme activity in Turkish patients with vitiligo.
    Aksoy SN; Erbagci Z; Saygili EI; Sever T; Erbagci AB; Pehlivan S
    Eur J Dermatol; 2009; 19(6):576-80. PubMed ID: 19758957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype.
    Aggarwal PK; Jain V; Srinivasan R; Jha V
    J Hypertens; 2009 Oct; 27(10):2044-50. PubMed ID: 19730395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of UVRAG polymorphisms with susceptibility to non-segmental vitiligo in a Korean sample.
    Jeong TJ; Shin MK; Uhm YK; Kim HJ; Chung JH; Lee MH
    Exp Dermatol; 2010 Aug; 19(8):e323-5. PubMed ID: 20163458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter polymorphisms of the HLA-G gene, but not the HLA-E and HLA-F genes, is associated with non-segmental vitiligo patients in the Korean population.
    Kim SK; Hong MS; Shin MK; Uhm YK; Chung JH; Lee MH
    Arch Dermatol Res; 2011 Nov; 303(9):679-84. PubMed ID: 21847675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between IL4 (-590), ACE (I)/(D), CCR5 (Delta32), CTLA4 (+49) and IL1-RN (VNTR in intron 2) gene polymorphisms and vitiligo.
    Pehlivan S; Ozkinay F; Alper S; Onay H; Yuksel E; Pehlivan M; Ozkinay C
    Eur J Dermatol; 2009; 19(2):126-8. PubMed ID: 19129082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population.
    Lemos MC; Fagulha A; Coutinho E; Gomes L; Bastos M; Barros L; Carrilho F; Geraldes E; Regateiro FJ; Carvalheiro M
    Hum Immunol; 2008 Feb; 69(2):134-8. PubMed ID: 18361940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.